Subscription banner for an ophthalmic newsletter

Breaking News

ViGeneron Rebrands as VeonGen, Earns FDA RPDD for Gene Therapy
ViGeneron Rebrands as VeonGen, Earns FDA RPDD for Gene Therapy Jun 16, 2025 VeonGen Therapeutics has officially announced its rebranding from ViGeneron, marking a strategic transformation into a clinical-stage genetic medicine company dedicated to developing innovative gene therapies for diseases with high unmet medical needs.
FDA Approves Amneal’s Prednisolone Acetate Ophthalmic Suspension for Steroid-Responsive Ocular Inflammation
FDA Approves Amneal’s Prednisolone Acetate Ophthalmic Suspension for Steroid-Responsive Ocular Inflammation Jun 13, 2025 Amneal Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved its prednisolone acetate ophthalmic suspension, 1%, a sterile topical anti-inflammatory agent intended for steroid-responsive ocular inflammation.
European Commission Approves Ryjunea for Slowing Progression of Pediatric Myopia
European Commission Approves Ryjunea for Slowing Progression of Pediatric Myopia Jun 10, 2025 The European Commission (EC) has granted marketing authorization for Ryjunea (SYD-101), Sydnexis’ proprietary low-dose atropine formulation.

 

a banner for OBN's Spotlight TV series. Showing 5 people in ophthalmic sector

Industry News

New Handheld Device Enhances Early Detection and Treatment of Amblyopia
New Handheld Device Enhances Early Detection and Treatment of Amblyopia Jun 17, 2025 Researchers at the University of Missouri–St. Louis (UMSL) have developed a groundbreaking handheld device designed to improve the early detection and treatment of amblyopia.
Heidelberg Engineering Launches ZinserLab to Drive Innovation in Ophthalmic Imaging
Heidelberg Engineering Launches ZinserLab to Drive Innovation in Ophthalmic Imaging Jun 17, 2025 Heidelberg Engineering has officially announced the launch of ZinserLab, an innovation hub dedicated to accelerating the development of clinically valuable imaging technologies for eye care.
FDA Clears Ocugen to Launch Phase 2/3 Confirmatory Trial of OCU410ST for Stargardt Disease
FDA Clears Ocugen to Launch Phase 2/3 Confirmatory Trial of OCU410ST for Stargardt Disease Jun 17, 2025 Ocugen has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2/3 pivotal confirmatory trial of OCU410ST, following approval of an Investigational New Drug (IND) amendment.

Ophthalmic Research News

Study Links Primary Open-Angle Glaucoma Diagnosis to Decline in Mental Health Scores
Study Links Primary Open-Angle Glaucoma Diagnosis to Decline in Mental Health Scores Jun 12, 2025 A recent study published in JAMA Ophthalmology reveals that a diagnosis of primary open-angle glaucoma (POAG) is associated with a measurable decline in mental health scores.
European Stroke Organization Issues First International Guideline for Visual Impairment Post-Stroke
European Stroke Organization Issues First International Guideline for Visual Impairment Post-Stroke Jun 03, 2025 A new international clinical guideline led by Professor Fiona Rowe of the University of Liverpool has been released to address the diagnosis and management of visual impairment in stroke survivors.
Genetic Research Offers New Hope for Patients with Inherited Retinal Diseases
Genetic Research Offers New Hope for Patients with Inherited Retinal Diseases Jun 02, 2025 Researchers at the University of Oklahoma are advancing the understanding of inherited retinal diseases (IRDs) through genetic mapping that may lead to more accurate diagnoses and lay the groundwork for future treatments.

Ophthalmic Blog

AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health Mar 07, 2025 The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies Dec 23, 2024 The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
2024 Recap: Top 8 FDA Approvals in Ophthalmology Dec 16, 2024 The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe